- May 25, 2009
Treating
type 2 diabetes
patients with a cholesterol-lowering drug called fenofibrate cuts the risk of a first diabetes-related limb amputation by 36%, according to a new study.
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial.
The Lancet, Volume 373, Issue 9677, Pages 1780 - 1788, 23 May 2009.
[Story at WebMD,
Abstract at
the Lancet;
full text at
the Lancet, requires registration.]
- May 18, 2009
A painless new method for detecting diabetes, using saliva, holds promise. Researchers identified 487 unique proteins,
of which 65 proteins indicated a difference between patients with normal blood glucose levels and those with diabetes.
[Story at USA Today,
Spit test shows promise in diagnosing, monitoring diabetes.
Abstract at AACE 2009 Abstracts,
Abstract #239
(PDF file)
Salivary biomarkers of type 2 diabetes: proteomic profiles for non-invasive diagnostics.]
- May 11, 2009
- New recommendations
are calling for major changes in the way health care professionals treat hospitalized patients with high blood glucose levels. The authors recommend revised glucose targets of 140-180 mg/dL in the ICU setting, and between 100-180 mg/dL for most patients admitted to general medical-surgical wards.
[Press release at Diabetes Monitor:
Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide.]
- May 1, 2009
The legendary performer Ben Vereen, an actor, dancer and singer, has taken the world stage by storm for more than 30 years...
He was diagnosed with
type 2 diabetes
in 2007.
"I want to get the word out that this is not a death sentence. It's a life sentence, if you become aware," Vereen said.
[Story at philly.com:
Legendary Ben Vereen dishes on diabetes.]
Advertisement
|
|
|
